3-[4-(azacycloundec-6-ylamino)cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide
C24H36F3N7O2S — CID 123858922
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[4-(azacycloundec-6-ylamino)cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide
3-[4-(azacycloundec-6-ylamino)cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide (PubChem CID 123858922) has the molecular formula C24H36F3N7O2S and a molecular weight of 543.66 g/mol. Its IUPAC name is 3-[4-(azacycloundec-6-ylamino)cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide.
Molecular Properties
| Compound Name | 3-[4-(azacycloundec-6-ylamino)cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide |
|---|---|
| PubChem CID | 123858922 |
| Molecular Formula | C24H36F3N7O2S |
| Molecular Weight | 543.66 g/mol |
| Exact Mass | 543.26 |
| IUPAC Name | 3-[4-(azacycloundec-6-ylamino)cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide |
| SMILES | NS(=O)(=O)c1c(C(F)(F)F)ccc(C2CCC(NC3CCCCCNCCCC3)CC2)c1-c1nn[nH]n1 |
| InChI | InChI=1S/C24H36F3N7O2S/c25-24(26,27)20-13-12-19(21(22(20)37(28,35)36)23-31-33-34-32-23)16-8-10-18(11-9-16)30-17-6-2-1-4-14-29-15-5-3-7-17/h12-13,16-18,29-30H,1-11,14-15H2,(H2,28,35,36)(H,31,32,33,34) |
| InChIKey | DWVDKLPPTPHJSI-UHFFFAOYSA-N |
| XLogP | 3.85 |
| TPSA | 138.68 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 543.66 |
| LogP ≤ 5 | 3.85 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 123858922 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.